Remove 2011 Remove Dosage Remove Pharmaceutical Companies
article thumbnail

Advanced Solutions for Sustained Delivery of Ocular Therapies

PharmTech

Pharmaceutical companies have responded with growing investment in the research and development of novel eye treatments and drug delivery systems designed to address key challenges in ocular therapy. PLoS ONE 2011 6, e24513. DOI:10.1089/jop.2022.0144 2022.0144 Natarajan, J.V.; Johnson & Johnson Vision.

Dosage 64
article thumbnail

Tracking the Drug Trail

Pharmaceutical Technology

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. Europe is favouring 2D data matrix codes to encode information while the US is tending more towards RFID.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ICH Q13 and What Is Next for Continuous Manufacturing

ISPE

Because the use of CM is expected to continue to grow beyond the current most common implementation for small molecule drug product, the focus on the guidance has been on general concepts that can be applied to any technology, dosage form, or molecule type. Published December 2011. ICH-Endorsed Guide for ICH Q8/Q9/Q10 Implementation.”

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Resolution RDC 10/2011. Published 24 March 2011.

article thumbnail

A Systemwide Approach to Managing the Risks of Continuous Manufacturing

ISPE

Advanced technologies such as CM have the potential to greatly transform pharmaceutical production processes by improving drug quality and supply continuity for consumers worldwide while benefiting the company’s bottom line. NASA Risk Management Handbook NASA/SP-2011-3422, Version 1.0. NASA Headquarters, 2011. Final Rule.

article thumbnail

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

ISPE

Going up in scale, in a CONTINUUS Pharmaceuticals and MIT collaboration, an end-to-end, QbD-driven integrated continuous manufacturing (ICM) pilot plant 8 was designed to produce both small molecule active pharmaceutical ingredient (API) and oral solid dosages. In 2021, CONTINUUS Pharmaceuticals secured a$69.3

article thumbnail

Thyroid Antibodies Part 2: Mechanisms to Reduce Thyroid Antibodies

The Thyroid Pharmacist

A dosage of 200 mcg per day has been found to reduce thyroid antibodies in clinical trials. [41] Many people have been able to eliminate their symptoms and reduce the dosage of their thyroid medications using LDN. 2011-0228 [2] Müssig K, Künle A, Säuberlich AL, et al. 2011-3350 [19] Eschler DC, Hasham A, Tomer Y.